Migraine.
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D004878:Ergotamine / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D008297:Male; D008784:Methysergide / Q000627:therapeutic use*; D008881:Migraine Disorders; D011379:Prognosis
D004878:Ergotamine; D008784:Methysergide